Veterinary Antibiotics Global Market Report 2026

Veterinary antibiotics constitute a category of animal medications designed to combat infectious diseases in animals. They achieve this by eliminating microorganisms such as bacteria and parasites, hindering the growth of their cell walls to effectively combat infections and diseases in animals, thereby enhancing the health conditions of the animals.

The primary product types within veterinary antibiotics encompass anti-parasitic drugs, anti-bacterial medications, non-steroidal anti-inflammatory drugs (NSAIDs), and other related products. NSAIDs serve as a connection point between the production and activity of prostaglandins (enzymes) involved in inflammation. Approved veterinary NSAIDs find application in companion animal care, specifically in mitigating pain and swelling associated with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes various methods such as premixes, injections, oral powders, oral solutions, and other forms, catering to both farm animals and companion animals.

Tariffs have influenced the veterinary antibiotics market by increasing the cost of imported drugs, premixes, and production equipment. Segments such as anti-bacterial and anti-parasitic drugs are most affected, particularly in Asia-Pacific, North America, and Europe where imports dominate supply chains. While tariffs raise costs, they may incentivize local production, enhance domestic research, and encourage development of cost-effective antibiotic solutions.

The veterinary antibiotics market research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics market statistics, including veterinary antibiotics industry global market size, regional shares, competitors with a veterinary antibiotics market share, detailed veterinary antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. This veterinary antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary antibiotics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to prevalence of bacterial infections in livestock, growth of companion animal population, limited early veterinary healthcare access, traditional injectable antibiotic formulations, rising awareness of animal welfare.

The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to adoption of precision medicine in veterinary care, innovation in oral and premix formulations, regulatory support for antibiotic stewardship, increasing pet ownership and spending, integration of digital monitoring in antibiotic administration. Major trends in the forecast period include rising demand for anti-bacterial and anti-parasitic drugs, expansion of companion animal antibiotic usage, shift toward oral solutions and premixes for easy administration, increasing focus on nsaids for livestock pain management, development of multi-functional veterinary antibiotic formulations.

The increasing pet ownership rate is expected to drive the growth of the veterinary antibiotics market in the coming years. Pet ownership refers to the legally recognized and responsible act of caring for domesticated animals as companions, which includes addressing their physical, emotional, and medical needs. This rate is rising due to a growing desire for companionship, as more individuals and families adopt pets to reduce loneliness and enhance emotional well-being. Veterinary antibiotics support this trend by keeping pets healthy and disease-free, providing owners with confidence in their ability to care for them. For example, in October 2024, according to the American Veterinary Medical Association, a US-based nonprofit professional association, the total number of dog-owning households in the U.S. is projected to reach 59.8 million in 2024 (45.5% of all U.S. households), while cat-owning households are expected to total 42.1 million (32.1% of all U.S. households). Therefore, the rising pet ownership rate is boosting the veterinary antibiotics market.

Key players in the veterinary antibiotics market are developing telemedicine platforms for pet healthcare to gain a competitive advantage. Telemedicine involves the remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technologies such as video calls, phone consultations, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation, launched Zoonivet, a digital pet-care app. This telehealth platform streamlines pet healthcare by connecting pet owners with qualified veterinarians via video consultations, making primary care accessible and convenient. Zoonivet also plans to offer surgery, home diagnostic services, medication, pet food, and pet boarding across key Indian markets.

In July 2024, Merck Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, nutritionals, and health management solutions for livestock, companion animals, and aquaculture, acquired Elanco Animal Health Incorporated's aqua business for approximately $1.3 billion. Through this acquisition, Merck aims to expand its global aquaculture portfolio and strengthen its scientific and commercial capabilities across warm-water and cold-water products to better support fish health, welfare, and sustainability. Elanco Animal Health Incorporated is a US-based provider of aquaculture-focused health solutions, including vaccines, anti-parasitic treatments, water supplements, and nutrition products for aquatic species, along with associated manufacturing and research operations.

Major companies operating in the veterinary antibiotics market are Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals plc, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Guangdong Wens Dahuanong Biotechnology Co. Ltd., Merial Pulike Biological Engineering, Ceva Sante Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E.

North America was the largest region in the veterinary antibiotics market in 2025. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Antibiotics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Anti-Parasitic; Anti-Bacterial; Non-Steroidal Anti-Inflammatory Drug; Other Products
• 2) By Administration: Premixes; Injections; Oral Powders; Oral Solutions; Other Administrations
• 3) By End User: Farm Animals; Companion Animals
• Subsegments:
• 1) By Anti-Parasitic: Endoparasiticides; Ectoparasiticides
• 2) By Anti-Bacterial: Tetracyclines; Penicillins; Macrolides; Aminoglycosides; Sulfonamides
• 3) By Non-Steroidal Anti-Inflammatory Drug (NSAID): Carprofen; Meloxicam; Aspirin
• 4) By Other Products: Antifungal; Antiviral
• Companies Mentioned: Boehringer Ingelheim GmbH; Zoetis, Inc.; Merck & Co., Inc.; Elanco Animal Health Incorporated; Vetoquinol S.A.; Phibro Animal Health Corporation; Kyoritsu Seiyaku Corporation; Dechra Pharmaceuticals plc; Bayer Animal Health China; China Animal Healthcare Ltd.; China Animal Husbandry Industry Corporation Ltd. (CAHIC); Guangdong Wens Dahuanong Biotechnology Co. Ltd.; Merial Pulike Biological Engineering; Ceva Sante Animale; Nimrod Veterinary Products Ltd.; Bimeda; VIRBAC SA; Orion Animal Health; Laboratorios Calier, SA; Petmedix; Eco Animal Health; Teknofarma; Farmavet; Candioli Pharma; Suanfarma; Marino Ibericamed; MPA veterinary; Lamons Laboratories SA; SUPER'S DIANA; Swetrade Pharmaceuticals AB; Animalcare; VIC Animal Health; AVZ animal health; Provet Group; VitOMEK LCC; Micro-plus; Biowet; Bioveta; Brovapharma; Evrovet; Ukrvetprompostach; VELELEK d.o.o; Veterinarski Zavod Subotica; VetPlanet; Delos Medica; Vetro Solutions; Belfarmacom; IDT Biologika; UCBVET; Syntec; Sauvet; Vetanco; Chemo Argentina; Brouwer; Agrovet Market Animal Health; Lemavet; Saudi Pharmaceutical Industries (SPI); DBK Pharma S.A.E.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.